Home
Portfolio
Class 12
About Us
Team
iSafe
Investor Hub
arrow-icon
Founders' Hub
arrow-icon
Partners
arrow-icon
News and Views
arrow-icon
Analyst Trainee Program
Contact Us
photo
100X.VC Team
Written by various collaborators within Team 100X.VC
Recent Memos
Inzpira: 100X Investment Thesis
Read more
Why We Invested in AgriGator
Read more
Roopya: 100X.VC Investment Thesis
Read more
DataKund: 100X Investment Thesis
Read more
date-icon
Jan 24, 2023
Topic

Introduction:

Complete Blood Count (CBC) test is one of the most common medical tests which one comes across, when it comes to any testing procedure. One goes for a CBC test to get checked for a wide range of blood disorders including anaemia, leukaemia and thrombocytopenia, or to see how medications, medical conditions, or treatments like chemotherapy are affecting your blood, or even explain common symptoms like weakness, fever, bruising, or feeling tired.

For the testing procedure, a nurse or lab tech will take a sample of blood by putting a needle into a vein in your arm. They’ll send the blood to a lab for review. You’ll get the results after a day. The seemingly simple procedure takes an entire day to complete. And when it comes to medical tests, every minute is critical.

But in the current scenario, patients are suffering as people have to wait hours or days to get their reports. There is no widespread availability of a basic CBC test. Conventional analysers are bulky, expensive, have high running costs and need a trained technician to operate. 

In order to address this seemingly simple but massive issue, 2 young entrepreneurs Hardik  from IIT Delhi and Apoorv, an ex-Innovaccer employee, came up with an ingenious device to address this issue in April 2020. 

They’ve created a device which not only allows samples to be taken individually and tested unlike traditional machines in which a load is taken in order to perform the test, but also offer the solution at a much cheaper cost. This not only reduces the whole procedure to mere 10 minutes, but also allows the blood testing equipment to reach every corner of Bharat due to its affordability and ability to be operated without a trained technician or a lab setup.

Over traditional equipment, their device offers:

  1. Portability- The device is portable and weighs just 4kgs

  2. Efficiency- The waiting time is reduced from 1-2 days in remote areas, to mere 10 minutes.
  3. Accessibility- There are no extra consumables required and no training needed to operate the device, thus increasing the reach

  4. Affordability- The strips are sold at a cost as low as Rs.100

This AI powered device provides 9 blood count parameters, and relieves the patient of using the traditional injection to take out blood, since it only requires 0.03ml of blood sample acquired through a finger prick.

Market Opportunity:

India houses 1.2mn Healthcare Professionals, 28K PHCs and CHCs and a massive 10.5L cancer Patients who are undergoing chemotherapy. As per reports, 1,300,000,000 CBC tests per year are needed to be prescribed by general physicians in India. Their target market extends from Doctors with clinics, hospitals, even Govt. agencies to fulfil sufficiencies for PHCs and CHCs, to companies which provide home testing services.

100X thesis:

The Adsys Team is building a portable CBC analyzer, which can generate an instantly shareable report in 10 minutes. They have done the right research background to be building this product. The product given its speed and portability will lead to massive consumer behaviour change as currently patients have to go to labs to get tested and wait hours. 

Conclusion:

Adsys has a vision to build great products that speak of quality and are rooted in the advancements of technology. Adsys wants to be looked up to be ‘The epitome of impeccable hardware with great software’. In the long term vision Adsys plans to work towards “Connected healthcare”, with a focus on the whole healthcare ecosystem. This connected healthcare ecosystem will allow the user to access one’s previous history whenever one gets a test done with an Adsys product. So whenever you think healthcare, you think Adsys.


 

Related topics
sales-logo
watch-logo.svg3 min
Inzpira: 100X Investment Thesis
Inzpira is an AI enabled, personalized soft skills training, simulator and measuring platform with a...
Read morenext-arrow
james100X.VC Team
May 19, 2021
sales-logo
watch-logo.svg3 Min min
Why We Invested in AgriGator
AgriGator is a digital platform where traders, millers and processors can buy & sell grain commoditi...
Read morenext-arrow
james100X.VC Team
Sep 14, 2020
sales-logo
watch-logo.svg3 min
Roopya: 100X.VC Investment Thesis
Read why 100X invested in Roopya which is India’s First ‘Specified User Fintech’ Powering Lenders wi...
Read morenext-arrow
Tags:
Fintech
james100X.VC Team
Jun 24, 2023
logo-footer
100X.VC is the first Venture Capital firm to invest in early stage startups using founder friendly India SAFE Notes.
Send Your pitches to us at:
www.100x.vc/class12
For other queries, please contact us at:
Portfolio
Class 12
About Us
Team
iSafe
Partners
Investor Hub
Founders Hub
News and Views
Contact Us
© 2000-2021, All Rights Reserved